Every material Form 8-K Xencor filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Xencor reported third-quarter 2024 results on November 6, 2024. Revenue fell to $10.7 million from $59.2 million a year earlier, and the net loss attributable to Xencor widened to $45.1 million, or $(0.71) per share, from $24.3 million, or $(0.40) per share. The company expects to end 2024 with between $690 million and $710 million in cash, cash equivalents and marketable debt securities.
Revenue was $10.7 million for the quarter ended September 30, 2024, versus $59.2 million a year earlier, mainly non-cash royalty revenue from Alexion and Incyte.
R&D expenses were $58.2 million, down from $64.9 million, while G&A expenses rose to $14.8 million from $12.5 million.
Other income, net was $16.0 million, compared with other expense, net of $6.0 million a year earlier.
Cash, cash equivalents and marketable debt securities were $754.3 million at September 30, 2024; year-end 2024 guidance is $690 million to $710 million.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Xencor filing is on SEC EDGAR ↗. 8-K briefs of other companies →